Medtech company Wenzel Spine received FDA clearance for panaSIa, an expandable sacroiliac fusion implant.
The implant offers a minimally invasive procedure option for patients with sacroiliac joint dysfunction, according to a July 15 news release from Wenzel Spine.
The approval marks the first FDA clearance of an expandable SI fusion implant.
The system separates the joint surfaces and minimizes micro-motion in the joint to provide immediate fixation and stabilize the joint for fusion, the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
